Optiver Holding
GLSI icon

Optiver Holding’s Greenwich LifeSciences GLSI Stock Holding History

Optiver Holding’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25K Hold
96
– – ﹤0.01% 2276
2026
Q1 		$2.31K Hold
96
– – ﹤0.01% 1791
2025
Q4 		$2.02K Hold
96
– – ﹤0.01% 2016
2025
Q3 		$955 Buy
+96
New +$1.08K ﹤0.01% 2505

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Optiver Holding's GLSI Position: Q2 2026 in Review

Optiver Holding held its Greenwich LifeSciences (GLSI) position steady in Q2 2026 at 96 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Optiver Holding first reported a position in GLSI in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.31K in Q1 2026. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Optiver Holding held 96 shares of Greenwich LifeSciences worth $2.25K as of Q2 2026.
  • Optiver Holding left its Greenwich LifeSciences share count unchanged in Q2 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2276 holding.
  • Optiver Holding first reported a position in Greenwich LifeSciences in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Greenwich LifeSciences position peaked at $2.31K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.